605 related articles for article (PubMed ID: 21376545)
41. Effect of oxygen plasma treatment on the release behaviors of poly(epsilon-caprolactone) microcapsules containing tocopherol.
Park SJ; Kim KS
Colloids Surf B Biointerfaces; 2005 Jul; 43(3-4):138-42. PubMed ID: 15936181
[TBL] [Abstract][Full Text] [Related]
42. Biocompatibility and bioactivity of plasma-treated biodegradable poly(butylene succinate).
Wang H; Ji J; Zhang W; Zhang Y; Jiang J; Wu Z; Pu S; Chu PK
Acta Biomater; 2009 Jan; 5(1):279-87. PubMed ID: 18760682
[TBL] [Abstract][Full Text] [Related]
43. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
44. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.
Porjazoska A; Goracinova K; Mladenovska K; Glavas M; Simonovska M; Janjević EI; Cvetkovska M
Acta Pharm; 2004 Sep; 54(3):215-29. PubMed ID: 15610618
[TBL] [Abstract][Full Text] [Related]
45. Influence of ether linkage on the enzymatic degradation of PBS copolymers: Comparative study on poly (butylene succinate-co-diethylene glycol succinate) and poly (butylene succinate-co-butylene diglycolic acid).
Li CT; Zhang M; Weng YX; Qin JX
Int J Biol Macromol; 2018 Oct; 118(Pt A):347-356. PubMed ID: 29933000
[TBL] [Abstract][Full Text] [Related]
46. Controlled release evaluation of bacterial fertilizer using polymer composites as matrix.
Wu CS
J Control Release; 2008 Nov; 132(1):42-8. PubMed ID: 18796320
[TBL] [Abstract][Full Text] [Related]
47. Multifunctional Nanobiocomposite of Poly[(butylene succinate)-co-adipate] and Clay.
Al-Thabaiti SA; Ray SS; Basahel SN; Mokhtar M
J Nanosci Nanotechnol; 2015 Mar; 15(3):2446-50. PubMed ID: 26413685
[TBL] [Abstract][Full Text] [Related]
48. Facile preparation of biodegradable chitosan derivative having poly(butylene glycol adipate) side chains.
Huang M; Fang Y
Biopolymers; 2006 Aug; 82(6):597-602. PubMed ID: 16552766
[TBL] [Abstract][Full Text] [Related]
49. Encapsulation of drug reservoirs in fibers by emulsion electrospinning: morphology characterization and preliminary release assessment.
Qi H; Hu P; Xu J; Wang A
Biomacromolecules; 2006 Aug; 7(8):2327-30. PubMed ID: 16903678
[TBL] [Abstract][Full Text] [Related]
50. Fabrication of microspheres using blends of poly(ethylene adipate) and poly(ethylene adipate)/poly(hydroxybutyrate-hydroxyvalerate) with poly(caprolactone): incorporation and release of bovine serum albumin.
Atkins TW
J Biomater Sci Polym Ed; 1997; 8(11):833-45. PubMed ID: 9342650
[TBL] [Abstract][Full Text] [Related]
51. Crystallization kinetics and morphology studies of biodegradable poly(butylene succinate-co-butylene adipate)/multi-walled carbon nanotubes nanocomposites.
Qiu Z; Zhu S; Yang W
J Nanosci Nanotechnol; 2009 Aug; 9(8):4961-9. PubMed ID: 19928174
[TBL] [Abstract][Full Text] [Related]
52. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
[TBL] [Abstract][Full Text] [Related]
53. Encapsulation of albumin in self-assembled layer-by-layer microcapsules: comparison of co-precipitation and adsorption techniques.
Labala S; Mandapalli PK; Bhatnagar S; Venuganti VV
Drug Dev Ind Pharm; 2015; 41(8):1302-10. PubMed ID: 25104114
[TBL] [Abstract][Full Text] [Related]
54. Effect of low loadings of cellulose nanocrystals on the significantly enhanced crystallization of biodegradable poly(butylene succinate-co-butylene adipate).
Li J; Qiu Z
Carbohydr Polym; 2019 Feb; 205():211-216. PubMed ID: 30446097
[TBL] [Abstract][Full Text] [Related]
55. Effect of cellulose structure and morphology on the properties of poly(butylene succinate-co-butylene adipate) biocomposites.
Avolio R; Graziano V; Pereira YD; Cocca M; Gentile G; Errico ME; Ambrogi V; Avella M
Carbohydr Polym; 2015 Nov; 133():408-20. PubMed ID: 26344297
[TBL] [Abstract][Full Text] [Related]
56. Porous devices derived from co-continuous polymer blends as a route for controlled drug release.
Salehi P; Sarazin P; Favis BD
Biomacromolecules; 2008 Apr; 9(4):1131-8. PubMed ID: 18355029
[TBL] [Abstract][Full Text] [Related]
57. Effect of surfactant on the characteristics of biodegradable microcapsules.
Graves RA; Moiseyev R; Freeman T; Mandal TK
J Biomater Sci Polym Ed; 2005; 16(5):585-96. PubMed ID: 16001718
[TBL] [Abstract][Full Text] [Related]
58. Mechanistic studies on the degradation and protein release characteristics of poly(lactic-co-glycolic-co-hydroxymethylglycolic acid) nanospheres.
Samadi N; van Nostrum CF; Vermonden T; Amidi M; Hennink WE
Biomacromolecules; 2013 Apr; 14(4):1044-53. PubMed ID: 23458350
[TBL] [Abstract][Full Text] [Related]
59. Intertwining lamellar assembly in porous spherulites composed of two ring-banded poly(ethylene adipate) and poly(butylene adipate).
Lugito G; Woo EM
Soft Matter; 2015 Feb; 11(5):908-17. PubMed ID: 25503816
[TBL] [Abstract][Full Text] [Related]
60. Development of poly(butylene succinate) microspheres for delivery of levodopa in the treatment of Parkinson's disease.
Mohanraj K; Sethuraman S; Krishnan UM
J Biomed Mater Res B Appl Biomater; 2013 Jul; 101(5):840-7. PubMed ID: 23401377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
